During the past decade, International Eye Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "International Eye Center" #1 sponsor was "Glaukos Corporation" with 2 trials, followed by "SOLX, Inc." with 2 trials sponsored, "Jaeb Center for Health Research" with 1 trials sponsored, "Lantibio" with 1 trials sponsored and "Merck Sharp & Dohme LLC" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "International Eye Center" #1 collaborator was "Allergan" with 1 trials as a collaborator, "National Eye Institute (NEI)" with 1 trials as a collaborator, "Novartis" with 1 trials as a collaborator, "River Plate Biotechnology, Inc." with 1 trials as a collaborator and "Rx Development Resources, LLC" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "International Eye Center" are "Glaucoma" (3 trials), "Glaucoma, Open Angle" (2 trials), "Age Related Macular Degeneration" (1 trials), "Bacterial Conjunctivitis" (1 trials) and "Choroidal Neovascularization" (1 trials). Many other conditions were trialed in "International Eye Center" in a lesser frequency.

Most popular intervention types in "International Eye Center" are "Device" (4 trials), "Drug" (4 trials), "Procedure" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "1mg triamcinolone acetonide" (1 trials), "4mg triamcinolone acetonide" (1 trials), "Ahmed FP7 Glaucoma Valve" (1 trials), "Argon Laser Trabeculoplasty (ALT)" (1 trials) and "AzaSite" (1 trials). Other intervention names were less common.

The vast majority of trials in "International Eye Center" are 9 trials for "All" genders.

Currently, there are NaN active trials in "International Eye Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in International Eye Center, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in International Eye Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".